Mitochondrial Transplantation Therapy: A Novel Approach in the Era of Organelle-Centered Regenerative Medicine
Frontiers in Bioscience-Landmark · 18.08.2025 · 30 (8)
DOI: 10.31083/fbl37006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 18.08.2025. Verfasst von Ha Rim Shin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, The Graduate School of Dong-A University, 49315 Busan, Republic of Korea. Hauptthemen laut MEDLINE: Regenerative Medicine, Mitochondria, Mitochondrial Replacement Therapy, Mitochondrial Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Dong-A University.
Abstract (Originalsprache)
Mitochondria play crucial roles in maintaining health and influencing disease progression by acting as central regulators of cellular homeostasis and energy production. Dysfunctions in mitochondrial activity are increasingly recognized as key contributors to various pathologies, ultimately impacting healthspan and disease outcomes. However, traditional treatments often do not restore damaged mitochondria to a healthy state. Mitochondrial transplantation, a cellular organelle-based therapy in which mitochondria are introduced into a recipient, has emerged as a novel concept in next-generation therapeutics that overcomes the limitations of current cell-based treatments. This review highlights the unique properties of mitochondria as therapeutic agents, including their ability to restore cellular functions and treat a wide range of diseases. In this review, we focus on the unique role of mitochondria in the regulation of stem cell functions, including stem cell fate, self-renewal, and differentiation. Various perspectives have been explored to better understand mitochondrial transplantation therapy, which harnesses the capacity of mitochondria as living drugs in regenerative medicine, as an innovative strategy to bridge the gap between cell therapy and organelle-based treatments and overcome current clinical barriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Health Sciences, The Graduate School of Dong-A University, 49315 Busan, Republic of Korea.
- Department of Health Care and Science, College of Health Science, Dong-A University, 49315 Busan, Republic of Korea.
Förderung
- National Research Foundation of Korea
- Dong-A University
Zitieren
APA
Shin, H. R., Lee, G., & Kim, K. H. (2025). Mitochondrial Transplantation Therapy: A Novel Approach in the Era of Organelle-Centered Regenerative Medicine. Frontiers in Bioscience-Landmark, 30(8). https://doi.org/10.31083/fbl37006
Vancouver
Shin HR, Lee G, Kim KH. Mitochondrial Transplantation Therapy: A Novel Approach in the Era of Organelle-Centered Regenerative Medicine. Frontiers in Bioscience-Landmark. 2025;30(8). doi:10.31083/fbl37006
BibTeX
@article{Shin2025,
author = {Shin, Ha Rim and Lee, Gaheon and Kim, Kyung Hwa},
title = {Mitochondrial Transplantation Therapy: A Novel Approach in the Era of Organelle-Centered Regenerative Medicine},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
volume = {30},
number = {8},
doi = {10.31083/fbl37006}
}
EUVIMED